Alpha-klotho and peritoneal membrane status: A hypothesis generating study
- PMID: 36377235
- DOI: 10.1111/eci.13903
Alpha-klotho and peritoneal membrane status: A hypothesis generating study
Abstract
Background: Long-term success of peritoneal dialysis relies on the integrity of the peritoneal membrane. This proof-of-concept study addressed the hypothesis that fibrosis is already present in the membrane at pre-dialysis and that the membrane status is related to the individual's uraemic fingerprint.
Methods: A clinical-mechanistic, transversal, single-centre study was conducted. Pre-dialysis peritoneal biopsies were scored considering the submesothelial compact zone thickness (STM), vasculopathy and inflammation. We investigated if the membrane status could be inferred from a panel of proteins (α-Klotho, Galectin-3, FGF21, FGF23, Tweak, TNFα and hsPCR) in blood.
Results: A total 58 incident patients aged 56 ± 15 years old were included, 31% female, 55% hypertension, 29% diabetic and 24% obese. Person-to-person STM was found to be highly variable and 38% of patients were fibrosis positive. Both α-Klotho (Spearman r = -.7491, p < 0.001) and FGF21 (Spearman r = -.5102, p < 0.001) were negatively associated with STM. α-Klotho, but not FGF21, was able to discriminate fibrosis from nonfibrosis with/without inflammation and vasculopathy. PLS models identified α-Klotho as the protein most relevant for fibrosis. α-Klotho was independently associated with fibrosis of the peritoneal membrane (OR = .991 (.896-.997), p = 0.002).
Conclusion: Before the start of dialysis in incident patients, some patients already present fibrosis of the peritoneal membrane and other patients do not. Our findings suggest that α-Klotho may be implicated in fibrosis of the peritoneal membrane.
Keywords: biopsy; cytokines; diabetes; peritoneal membrane fibrosis; precision medicine; uraemic toxins.
© 2022 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant. 2012;27(9):3568-3575.
-
- Escoli R, Carvalho MJ, Cabrita A, Rodrigues A. Diastolic dysfunction, an underestimated new challenge in dialysis. Ther Apher Dial. 2019;23(2):108-117.
-
- Cho Y, Bello AK, Levin A, et al. Peritoneal dialysis use and practice patterns: an international survey study. Am J Kidney Dis. 2021;77(3):315-325.
-
- Kunin M, Beckerman P. The peritoneal membrane-a potential mediator of fibrosis and inflammation among heart failure patients on peritoneal dialysis. Membranes. 2022;12(3):318.
-
- Silva F, Calça R, Martins AR, et al. Is peritoneal dialysis an effective treatment for cardiorenal syndrome with decompensated heart failure? A single center experience. Med Clin Res. 2022;7(2):12-17.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources